Find a Trial
Trial Summary
| Protocol No. | PHO-FALLON-COG-AALL1621 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Batra, Sandeep | ||
| Scope | National | ||
| Phase | Phase II | ||
| Age Group | Children | ||
| Title | AALL1621, A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518, IND#133494) in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL) | ||
| Description | |||
| Key Eligibility | |||
| Applicable Disease Sites | Leukemia, other | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Treatment | ||